For individuals experiencing HIV-associated fat maldistribution, a challenging condition characterized by loss of peripheral fat in the limbs and accumulation around the midsection, the drug Tesamorelin presents a https://tesamorelin445094.newsyblog.com/2808670/tesamorelin-a-new-approach-to-lipodystrophy